Authors: Merli, G Spiro, TE Olsson, CG Abildgaard, U Davidson, BL Eldor, A Elias, D Grigg, A Musset, D Rodgers, GM Trowbridge, AA Yusen, RD Zawilska, K

Citation: G. Merli et al., Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease, ANN INT MED, 134(3), 2001, pp. 191-202

Authors: Lopaciuk, S Bielska-Falda, H Noszczyk, W Bielawiec, M Witkiewicz, W Filipecki, S Michalak, J Ciesielski, L Mackiewicz, Z Czestochowska, E Zawilska, K Cencora, A Tomkowski, WZ Hajduk, B Kloczko, J Mazgajska, K Jaromin, J Chmielecki, Z Niedziela, P Czekalski, P Molski, S Kwiatkowski, C Psuja, P Lewandowski, K Muszynski, R Kicinska, M

Citation: S. Lopaciuk et al., Low molecular weight heparin versus acenocoumarol in the secondary prophylaxis of deep vein thrombosis, THROMB HAEM, 81(1), 1999, pp. 26-31

Authors: Grzywacz, A Psuja, P Zozulinska, M Elikowski, W Zawilska, K

Citation: A. Grzywacz et al., Elevation of plasma fibrinogen in silent myocardial ischaemia, ACT BIOCH P, 46(4), 1999, pp. 985-989